Search Results

Ordering information regarding a Cyclic Citrullinated Peptide (CCP) Antibody, IgG test for Clinical Diagnostic Laboratories. Cyclic Citrullinated Peptide (CCP) Antibody, IgG Ordering Recommendation Highly specific serologic test that aids in the workup of suspected rheumatoid arthritis or undifferentiated inflammatory arthritides. Rheumatoid Arthritis Panel (3004055 ) is the preferred test. Mnemonic Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube (SST). Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated Unacceptable Conditions: Urine or plasma. Contaminated, hemolyzed, grossly icteric, heat-inactivated, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 19 Units or less 20-39 Units Negative Weak Positive 40-59 Units Moderate Positive 60 Units or Greater Strong Positive Interpretive Data Anti-cyclic citrullinated peptide (anti-CCP), IgG antibodies are present in about 69-83 percent of patients with rheumatoid arthritis (RA) and have specificities of 93-95 percent. These autoantibodies may be present in the preclinical phase of disease, are associated with future RA development, and may predict radiographic joint destruction. Patients with weak positive results should be monitored and testing repeated. Note CPT Code 86200 Components Component Chart Name Cyclic Citrullinated Peptide Ab, IgG Component Test Code 0055256 LOINC 33935-8 Aliases ACPA Antibody Anti Citrullinated Antibody Anti Citrulline Anti-CCP Anti-CCP Antibody Anti-Citrullinated Ab Anti-Citrullinated Antibody Anti-Citrullinated Protein/Peptide Antibody (ACPA) Anti-Citrulline Antibody Anti-Cyclic Citrullinated Peptide AntiCCP Antibody Anticitrullinated Antibody Anticitrullinated Protein/Peptide Antibody (ACPA) Anticitrulline Antibody Anticyclic Citrullinated Peptide (CCP) Antibody CCP CCP3 Antibody Citrullinated Ab Citrullinated Antibody Citrullinated Protein/Peptide Antibody (ACPA) Citrulline An tibody Soft-CCP

Ordering information regarding a Hemoglobin A1C test for Clinical Diagnostic Laboratories. Hemoglobin A1C Ordering Recommendation The Hemoglobin A1c test is a vital tool for diagnosing and monitoring diabetes mellitus, as well as assessing prediabetes. Diagnostic levels are marked by values greater than or equal to 6.5%, while monitoring involves tracking long-term glycemic control in diabetes patients. Additionally, values between 5.7% and 6.4% signal an increased risk of developing diabetes. For patients with hemoglobin variants lacking hemoglobin A, the Fructosamine test is preferred for monitoring long-term glycemic control. Mnemonic Methodology Quantitative Capillary Electrophoresis Performed Mon-Sat Reported Within 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Lavender (EDTA) Specimen Preparation: Transport whole blood in original tube. (Min: 1 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Tissue or urine. Samples frozen after 8 hrs of collection and samples frozen at temperatures less than -70C. Remarks: Stability: Ambient: 72 hours; Refrigerated: 1 week; Frozen: 3 months (Must be frozen within 8 hrs of collection at -70 to -80C) Reference Interval Components Available Separately Reference Interval No Hemoglobin A1C Less than 5.7 percent No Estimated Average Glucose By report Interpretive Data HbA1c values of 5.7-6.4 percent indicate an increased risk for developing diabetes mellitus. HbA1c values greater than or equal to 6.5 percent are diagnostic of diabetes mellitus. For diagnosis of diabetes in individuals without unequivocal hyperglycemia, results should be confirmed by repeat testing. Note This assay accurately measures hemoglobin A1c even in the presence of hemoglobin variants, provided hemoglobin A is present. For patients with known hemoglobin variants who lack hemoglobin A, it is recommended to monitor long-term glycemic control using the Fructosamine test CPT Code 83036 Components Component Test Code 0070427 0070428 Component Chart Name Estimated Average Glucose LOINC Hemoglobin A1C 27353-2 4548-4 Aliases Hemoglobin A1C A1C A1C Hemoglobin Glycated Hemoglobin Glyco HGB Glyco-Hb Glycosylated Hemoglobin HA1C HbA1c Hemoglobin A1C Hemoglobin A1C, Blood

Services for Government Agencies Clinical Diagnostics Laboratories does not currently work with any government agencies but we are registered in the same database and are a female-owned and operated, minority company. Clinical Diagnostics Laboratories is always available and open for opportunities. If you're interested in learning more about our services or are interested in working with us, please contact us for more information. CONTACT US

Ordering information regarding a Cardiolipin Antibody, IgA test for Clinical Diagnostic Laboratories. Cardiolipin Antibody, IgA Ordering Recommendation Preferred second-line test when seronegative antiphospholipid syndrome (APS) is strongly suspected. Order incrementally or concurrently with other noncriteria antiphospholipid antibody tests. Mnemonic CARDIO IGA Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported 1-2 days New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma or other body fluids. Contaminated, heat-inactivated, hemolyzed, or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval <=12 MPL Negative 13-19 MPL Indeterminate 20-80 MPL Low to Moderately Positive 81 MPL or above High Positive Interpretive Data The persistent presence of IgG and/or IgM cardiolipin (CL) antibodies in moderate or high levels (greater than 40 GPL and/or greater than 40 MPL units) is a laboratory criterion for the diagnosis of antiphospholipid syndrome (APS). Persistence is defined as moderate or high levels of IgG and/or IgM CL antibodies detected in two or more specimens drawn at least 12 weeks apart (J Throm Haemost. 2006;4:295-306). Lower positive levels of IgG and/or IgM CL antibodies (above cutoff but less than 40 GPL and/or less than 40 MPL units) may occur in patients with the clinical symptoms of APS; therefore, the actual significance of these levels is undefined. Results should not be used alone for diagnosis and must be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests. Compliance Category: FDA Note MPL = IgM phospholipid units CPT Code 86147 Components Component Chart Name Cardiolipin Antibody IgM Component Test Code 0050902 LOINC 3182-3 Aliases ACA aCL aCL Antibody aCL IgG Anti-Cardiolipin Anticardiolipin Anticardiolipin Antibodies Cardiolip

The product page for the Immunochemical Test at Clinical Diagnostic Laboratories. InSure ONE - One Day Fecal Immunochemical Test *The Fecal Immunochemical kit, as well as a prepaid return envelope, will be shipped to you* A simple, non-invasive test that helps you screen for early signs of colon cancer — from the comfort of home. No doctor’s order, no insurance, no hassle. Colon cancer often develops silently, with no symptoms in the early stages. The InSure® ONE FIT test makes it easy to check for hidden blood in your stool, a key early indicator of colorectal disease, so you can take control of your health before problems become serious. This test is quick, clean, and designed for anyone who wants reliable screening without the stress of appointments, referrals, or long waits. A highly sensitive test that detects tiny, invisible traces of blood in your stool — something you can’t see on your own. Uses advanced antibody technology to identify blood from the lower colon. Does not require diet changes, fasting, or multiple stool samples. Helps identify early warning signs of colon cancer, polyps, or gastrointestinal bleeding. Even if you feel completely fine, FIT testing is one of the easiest and most effective ways to stay ahead of colorectal health issues. Why people choose the InSure® ONE FIT test: Simple at-home collection — no mess and no bathroom handling. Only one sample required — done in minutes. No dietary restrictions before completing the test. Great for routine screening or peace of mind between doctor visits. Fast, accurate processing by our CLIA-certified lab. Ideal for adults who prefer private, accessible screening without insurance barriers. Who is this test for? Perfect for individuals who want: A quick annual colorectal cancer screening A private, self-pay option without waiting for a doctor’s appointment Monitoring between colonoscopies (as advised by a physician) A simple way to stay proactive about their health $35.50 Taxes will be calculated at checkout Buy Now

Ordering information regarding a Thyroid Peroxidase (TPO) Antibody test for Clinical Diagnostic Laboratories. Thyroid Peroxidase (TPO) Antibody Ordering Recommendation Not recommended for initial thyroid disorders testing. Distinguish thyroid autoimmune disorders from nonautoimmune disease or hypothyroidism. Mnemonic AMICR Methodology Quantitative Chemiluminescent Immunoassay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Also acceptable: Lavender (EDTA), pink (K2 EDTA), or green (sodium or lithium heparin). Specimen Preparation: Transfer 0.5 mL serum or plasma to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Grossly hemolyzed or lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 8 hours; Refrigerated: 1 week; Frozen: 6 months Reference Interval 0.0-9.0 IU/mL Interpretive Data Compliance Category: FDA Note CPT Code 86376 Components Component Chart Name Thyroid Peroxidase (TPO) Antibody Component Test Code 0050075 LOINC 8099-4 Aliases Anti-Microsomal Antibody Anti-TPO Antimicrosomal Antibody Antithyroid Antibodies Antithyroid Antibodies, Microsomal Antibodies Microsomal Antibodies, MMLNE Microsomal Antibody Thyroid Antibody Group Thyroid Autoantibodies Thyroid Microsomal Ab Thyroid Microsomal Antibody Thyroid Peroxidase Thyroperoxidase Antibody TPOAb

OOPS! There’s Nothing Here...yet. Clinical Diagnostic Laboratories is working hard to make the experience for our physicians and patients as seamless as possible. The page you’re looking for is still under construction. Please come back at a later date or Contact Us if you have any questions. Back to Homepage